Will the Revision of the EU General Pharmaceutical Legislation Improve Access, Affordability, and Availability of New Medicines? An Interactive "Moot" Style Debate

ISSUE: Stakeholders from across the healthcare and life science spectrum are watching as the European Parliament and the Member State representatives in the Council debate the legislative proposal of the Commission to substantially review the EU’s legislative framework for pharmaceuticals. The common goal is to ensure better and faster access, availability and affordability of new medicines in all EU Member States. But how well are the needs of patients and the member states’ healthcare systems addressed? Will the proposals and counter-proposals really meet their needs?

OVERVIEW:

• Voices from the key healthcare communities will offer their perspectives on the proposed legislative changes and discuss how they might impact patient access at a national level.

• Opening (12 minutes) : the moderator (Petra Wilson, FTI) will open the proceedings by outlining the case that has arisen and presenting the positions of the European Commission and European Parliament. Following these position statements, the moderator (moot judge) will call for expert evidence to help the audience to vote.

• Expert Evidence from Panelists (3 x 12 minutes):

• The needs of patients (Strammiello – EPF)

• The needs of the rare disease community (Bros-Facer – EURORDIS)

• The needs of the national buyers (Ponten – Sweden)

• The moderator will ask the Jury (audience) if they need additional information before voting - 10 minutes questions and interventions from the floor

• To make this session more interactive, the voting will take place on-line using the mobile phones on the ISPOR platform. On the screen in the room it will be possible to follow the voting, put questions and comments forward and use it as a platform to comment on the presentations and agree/disagree with the promotor and the opposer. This should take place “real-time” in a lively way to imitate the type of debates that would normally take place in a national parliament.